1. An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system. (January 2019) Authors: Larkin, James; Brown, Michael P.; Arance, Ana M.; Hauschild, Axel; Queirolo, Paola; Vecchio, Michele Del; Ascierto, Paolo A.; Krajsová, Ivana; Schachter, Jacob; Neyns, Bart; Garbe, Claus; Sileni, Vanna Chiarion; Mandalà, Mario; Gogas, Helen; Espinosa, Enrique; Hospers, Geke; Lorigan, Paul; Nyakas... Journal: European journal of cancer Issue: Volume 107(2019) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biomarkers for outcome upon MAPK inhibition in melanoma. Issue 12 (December 2016) Authors: Blank, Christian Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: 1634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. (February 2022) Authors: Goldinger, Simone M.; Buder-Bakhaya, Kristina; Lo, Serigne N.; Forschner, Andrea; McKean, Meredith; Zimmer, Lisa; Khoo, Chloe; Dummer, Reinhard; Eroglu, Zeynep; Buchbinder, Elizabeth I.; Ascierto, Paolo A.; Gutzmer, Ralf; Rozeman, Elisa A.; Hoeller, Christoph; Johnson, Douglas B.; Gesierich, Anja... Journal: European journal of cancer Issue: Volume 162(2022) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial. (24th November 2021) Authors: Abu‐Ghanem, Yasmin; van Thienen, Johannes V.; Blank, Christian; Aarts, Maureen J. B.; Jewett, Michael; de Jong, Igle Jan; Lattouf, Jean‐Baptiste; van Melick, Harm H. E.; Wood, Lori; Mulders, Peter; Rottey, Sylvie; Wagstaff, John; Zondervan, Patricia; Powles, Tom; Neven, Anouk; Collette, Laurence;... Journal: BJU international Issue: Volume 130:Number 1(2022) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dabrafenib for the treatment of BRAF V600-positive melanoma: a safety evaluation. (September 2014) Authors: Rutkowski, Piotr; Blank, Christian Journal: Expert opinion on drug safety Issue: Volume 13:Number 9(2014) Page Start: 1249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins. Issue 7 (12th July 2022) Authors: Fessenden, Tim B; Stopfer, Lauren E; Chatterjee, Fiona; Zulueta, Julian; Mesfin, Josh; Cordero Dumit, Therese; Reijers, Irene; Hoefsmit, Esmee P; Blank, Christian; White, Forest; Spranger, Stefani Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial. (March 2018) Authors: Tacke, Moritz; Borggraefe, Ingo; Gerstl, Lucia; Heinen, Florian; Vill, Katharina; Bonfert, Michaela; Bast, Thomas; Neubauer, Bernd Axel; Baumeister, Friedrich; Baethmann, Martina; Bentele, Karl; Blank, Christian; Blank, Harald M.; Bode, Harald; Bosch, Friedrich; Brandl, Ulrich; Brockmann, Knut; D... Journal: Seizure Issue: Volume 56(2018) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of neoadjuvant systemic therapy on surgery time and postoperative complications of lymph node dissections in stage III melanoma. Issue 2 (February 2023) Authors: Zijlker, Lisanne; van der Burg, Stijn; Blank, Christian; Zuur, Charlotte; Klop, Martin; Wouters, Michel; van Houdt, Winan; van Akkooi, Alexander Journal: European journal of surgical oncology Issue: Volume 49:Issue 2(2023) Page Start: e34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma. (July 2019) Authors: Kreft, Sophia; Gesierich, Anja; Eigentler, Thomas; Franklin, Cindy; Valpione, Sara; Ugurel, Selma; Utikal, Jochen; Haferkamp, Sebastian; Blank, Christian; Larkin, James; Garbe, Claus; Schadendorf, Dirk; Lorigan, Paul; Schilling, Bastian Journal: European journal of cancer Issue: Volume 116(2019) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. (November 2017) Authors: Hamid, Omid; Puzanov, Igor; Dummer, Reinhard; Schachter, Jacob; Daud, Adil; Schadendorf, Dirk; Blank, Christian; Cranmer, Lee D.; Robert, Caroline; Pavlick, Anna C.; Gonzalez, Rene; Hodi, F. Stephen; Ascierto, Paolo A.; Salama, April K.S.; Margolin, Kim A.; Gangadhar, Tara C.; Wei, Ziwen; Ebbingh... Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗